Table 5. Heart rate summary: capsazepine protocol.
| Intact | Capsazepine | Recovery | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Challenge | Baseline(bpm) | Decrease(%) | Latency(s) | Baseline(bpm) | Decrease(%) | Latency(s) | Baseline(bpm) | Decrease(%) | Latency(s) |
| Saline | 185.2 ± 4.4 | 4.3 ± 1.1* | 4.0 ± 0.3 | n. a. | n. a. | n. a. | n. a. | n. a. | n. a. |
| CAPS | 205.6 ± 6.3 | 8.0 ± 2.9*‡ | 4.6 ± 1.4 | 207.7 ± 5.8 | 6.4 ± 2.4* | 5.0 ± 1.5 | 214.6 ± 9.3 | 5.4 ± 3.1* | 4.6 ± 1.9 |
| LA | 180.6 ± 5.6 | 31.1 ± 7.8*†‡ | 6.8 ± 2.8 | 207.4 ± 5.5 | 33.3 ± 10.4*† | 6.0 ± 0.9 | 212.9 ± 11.9 | 36.1 ± 8.5*† | 8.6 ± 3.8 |
bpm, beats per minute.
Significantly different from baseline value (P < 0.05)
significantly different from capsaicin (P < 0.05)
significantly different from saline (P < 0.05); n. a., not applicable. Values are means ± S.E.M.